Subscription Center
The Institute of Medicine reveals a "blueprint" for relieving Americans' pervasive chronic pain
Researchers have found new ways to interfere with a co-receptor important to HIV infection, and the outcomes so far are encouraging
Drug policy has focused on a policing approach of prohibition and incarceration, which has contributed to spreading HIV within the injection-drug community. Comprehensive drug reform policies are showing better results
NIH researchers may have found antibodies that can neutralize most varieties of HIV, blocking it before it infects healthy cells. But stimulating their sparse natural production remains a hurdle in developing an antiviral therapy
A series of promising compounds can cripple all enveloped viruses' ability to invade cells as well as circumvent any resistance that hobbles traditional antiviral drugs. But will they work outside the lab?
Are "elite controllers" the key to understanding HIV infection—and do their immune systems offer a new approach to developing an AIDS vaccine?
See what we're tweeting about
Dhunterauthor Neo-Rosetta Stones: The Cataclysm: “From Unbaked Fragments to Vitreous Charcoal” http://t.co/uihqm2BU9M
kahoakes The Economist explains: How does copyright work in space? http://t.co/7ksaBkwjdq
BecCrew RT @screen_info Congratulations to @BadenPailthorpe! http://t.co/4gc6DfL1gN
Deadline: Jul 30 2013
Reward: $100,000 USD
The Seeker desires a method for producing pseudoephedrine products in such a way that it will be extremely difficult for clandestine che
Deadline: Jun 29 2013
Reward: $7,000 USD
The Seeker for this Challenge desires proposals for chemical methods that could rapidly degrade a dilute aqueous solution
Powered By: 
YES! Send me a free issue of Scientific American with no obligation to continue the subscription. If I like it, I will be billed for the one-year subscription.
